Privia Health Group, Inc. provided earnings guidance for the year 2022. For the year, the company expects GAAP revenue of $1,225 million to $1,300 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.37 USD | +0.64% | +0.35% | -24.58% |
30/05 | Baird Starts Privia Health Group With Outperform Rating, $23 Price Target | MT |
20/05 | Barclays Adjusts Price Target on Privia Health to $19 From $22, Maintains Equalweight Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.58% | 207.26Cr | |
+25.52% | 8.9TCr | |
-24.52% | 7.48TCr | |
+0.49% | 2.66TCr | |
+4.31% | 1.79TCr | |
-14.25% | 1.64TCr | |
+2.97% | 1.58TCr | |
+79.20% | 1.32TCr | |
+70.11% | 1.31TCr | |
+40.44% | 1.29TCr |
- Stock Market
- Equities
- PRVA Stock
- News Privia Health Group, Inc.
- Privia Health Group, Inc. Provides Earnings Guidance for the Year 2022